Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes
This study aimed at assessing the effects of chamomile tea consumption on glycemic control and serum lipid profile in patients with type 2 diabetes mellitus (T2DM).
This single-blind randomized controlled clinical trial was conducted on 64 individuals with T2DM (males and females) aged between 30 and 60 years. The intervention group (n = 32) consumed chamomile tea (3 g/150 mL hot water) three times per day immediately after meals for 8 weeks. The control group (n = 32) followed a water regimen for the same intervention period. Fasting blood samples, anthropometric measurements, and 3-day, 24-h dietary recalls were collected at the baseline and at the end of the trial. Data were analyzed by independent t test, paired t test, Pearson correlation test, and analysis of covariance.
Chamomile tea significantly decreased concentration of HbA1C (p = 0.03), serum insulin levels (p < 0.001), homeostatic model assessment for insulin resistance (p < 0.001), total cholesterol (p = 0.001), triglyceride (p < 0.001), and low-density lipoprotein cholesterol (p = 0.05) compared with control group. No significant changes were shown in serum high-density lipoprotein cholesterol levels in both groups.
Chamomile tea has some beneficial effects on glycemic control and serum lipid profile in T2DM patients.
KeywordsType 2 diabetes mellitus Chamomile Glycemic control Serum lipids
- 1.IDF (2009) Diabetes and impaired glucose tolerance. Global burden: prevalence and projections 2010 and 2030. http://www.idf.org/diabetesatlas/diabetes-and-impaired-glucose-tolerance
- 2.IDF (2011) Diabetes atlas, 5th edn. 2011 International Diabetes Federation. www.idf.org/diabetesatlas/papers
- 3.Nolte MS, Karam JH (2004) Pancreatic hormones and antidiabetic drugs. Basic Clin Pharmacol 9:693–715Google Scholar
- 4.Holman RR, Turner RC (1991) Oral agent and insulin in the treatment of NIDDM. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Publication, Oxford, pp 467–469Google Scholar
- 7.Franke R, Schilcher H (2005) Chamomile: industrial profiles (medicinal and aromatic plants). CRC Press, Boca RatonGoogle Scholar
- 11.Azzi R, Djaziri R, Lahfa F, Sekkal FZ, Benmehdi H, Belkacem N (2012) Ethnopharmacological survey of medicinal plants used in the traditional treatment of diabetes mellitus in the North Western and South Western Algeria. J Med Plants Res 6:2041–2050Google Scholar
- 14.Ramadan KS, Emam MA (2012) Biochemical evaluation of antihyperglycemic and antioxidative effects of matricaria chamomilla leave extract studied in streptozotocin-induced diabetic rats. Int J Res Manag Technol 2:298–302Google Scholar
- 19.Darvishpadok A, Azemi M, Namjoyan F, Khodayar M, Ahmadpour F, Panahi M (2012) Effect of Matricaria chamomilla L. on blood glucose and glycosylated hemoglobin in female fertile diabetic rats. Res Pharm Sci 7:19Google Scholar
- 20.De Lima VLAG, Melo ED, Lima DES (2004) Total phenolic content in Brazilian teas. Brazil J Food Technol 7(2):187–190Google Scholar
- 23.Najla OA, Olfat AK, Kholoud SR, Enas ND, I Hanan SA (2012) Hypoglycemic and biochemical effects of Matricaria Chamomilla leave extract in streptozotocin-induced diabetic rats. J Health Sci 2:42–48Google Scholar
- 24.Weidner C, Wowro SJ, Rousseau M, Freiwald A, Kodelja V, Abdel-Aziz H, Sauer S (2013) Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family. PLoS One 8:1–16Google Scholar
- 33.Al-Jubouri HHF, Al-Jalil BH, Farid I, Jasim F, Wehbi S (1990) The effect of chamomile on hyperlipidemias in rats. J Fac Med Baghdad 32:5–11Google Scholar
- 38.Kalra A, Sreekumaran N, Lavanya R (2006) Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci 60:11Google Scholar
- 43.Harrington WW, Britt SC, Wilson JG, Milliken NO, Binz JG, Lobe DC, Oliver WR, Lewis MC, Oliver WR, Ignar DM (2007) The effect of PPARα, PPARδ, PPARγ, and PPARpan agonists on bodyweight, bodymass, and serum lipid profiles in diet-induced obese AKR/J mice. PPAR Res: 1–13Google Scholar